Large Study of Subtle, Rare Genetic Differences Reveals Several New Clinically Relevant Targets for Variety of Diseases

A large, multicenter study led by researchers at Children’s Hospital of Philadelphia (CHOP) compared the genomic data of more than 100,000 people of European ancestry and discovered how relatively rare, albeit recurrent, genetic variations can influence a variety of common diseases. In addition, existing drugs could be repurposed to target these conditions – ranging from autoimmune diseases to neuropsychological diseases and even cancer – now that the genetic underpinnings of these conditions are known.

Source link

Related posts

Guns Used Far More Often for Suicide Than Self-Defense


Developing a Clinical Pathway for Somatic Symptom and Related Disorders in Pediatric Hospital Settings


Surgeon General Calls for New E-Cig Restrictions


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World